BioCentury | Jan 11, 2020
Company News

Led by Blatt, Aligos reunites Alios team to develop functional cure for HBV

...S-antigen Transport-inhibiting Oligonucleotide Polymers (STOPs), comes in. Instead of directly targeting HBsAg, Aligos’ STOP therapy, ALG-010133...
...was co-invented by Aligos and the university. The series B funds are intended to move ALG-010133...
Items per page:
1 - 1 of 1